Trials / Recruiting
RecruitingNCT07222995
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
A Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in Federal Qualified Health Centers
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,900 (estimated)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine how different messages about risk of skin cancer can impact the uptake of skin cancer prevention activities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Precision Prevention Booklet | Precision prevention booklet anchored in their MC1R risk that incorporates gold-standard risk communication strategies, including visual risk representations and simple language. |
| BEHAVIORAL | Standard Prevention Booklet | Standard materials are similar in content to the precision prevention booklet but without any reference to MC1R risk. |
Timeline
- Start date
- 2025-10-10
- Primary completion
- 2030-10-10
- Completion
- 2030-10-10
- First posted
- 2025-10-31
- Last updated
- 2026-02-05
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07222995. Inclusion in this directory is not an endorsement.